P. Østergaard

1.3k total citations
31 papers, 1.1k citations indexed

About

P. Østergaard is a scholar working on Hematology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, P. Østergaard has authored 31 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hematology, 8 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in P. Østergaard's work include Venous Thromboembolism Diagnosis and Management (8 papers), Proteoglycans and glycosaminoglycans research (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). P. Østergaard is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (8 papers), Proteoglycans and glycosaminoglycans research (7 papers) and Blood Coagulation and Thrombosis Mechanisms (6 papers). P. Østergaard collaborates with scholars based in Denmark, Sweden and United Kingdom. P. Østergaard's co-authors include G.J. Davies, Ulla Hedner, Keith S. Wilson, A.M. Brzozowski, Palle Schneider, Klas Norrby, David Bergqvist, Debbie Yaver, Stephen H.M. Brown and Anders H. Pedersen and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Molecular Biology and Journal of Bone and Joint Surgery.

In The Last Decade

P. Østergaard

30 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Østergaard Denmark 19 280 277 264 240 198 31 1.1k
Franz Koller Austria 17 231 0.8× 429 1.5× 24 0.1× 136 0.6× 68 0.3× 36 1.2k
L.-O. Andersson Sweden 14 48 0.2× 335 1.2× 211 0.8× 198 0.8× 321 1.6× 30 1.3k
Anders H. Pedersen Denmark 13 301 1.1× 408 1.5× 24 0.1× 26 0.1× 97 0.5× 14 1.4k
Simeon Pollack United States 23 113 0.4× 262 0.9× 16 0.1× 28 0.1× 75 0.4× 64 1.6k
Utpal Chaudhuri India 16 50 0.2× 480 1.7× 20 0.1× 54 0.2× 59 0.3× 51 1.3k
Jimmy D. Page United States 14 21 0.1× 310 1.1× 78 0.3× 135 0.6× 41 0.2× 20 981
V. M. Berlin Grace India 20 158 0.6× 584 2.1× 9 0.0× 146 0.6× 78 0.4× 59 1.2k
Werner Stüber Germany 14 8 0.0× 210 0.8× 76 0.3× 114 0.5× 23 0.1× 30 889
Isabel Gómez-Orellana Spain 11 33 0.1× 309 1.1× 24 0.1× 23 0.1× 38 0.2× 17 922
H. K. Kim South Korea 15 34 0.1× 251 0.9× 5 0.0× 72 0.3× 15 0.1× 26 1.0k

Countries citing papers authored by P. Østergaard

Since Specialization
Citations

This map shows the geographic impact of P. Østergaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Østergaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Østergaard more than expected).

Fields of papers citing papers by P. Østergaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Østergaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Østergaard. The network helps show where P. Østergaard may publish in the future.

Co-authorship network of co-authors of P. Østergaard

This figure shows the co-authorship network connecting the top 25 collaborators of P. Østergaard. A scholar is included among the top collaborators of P. Østergaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Østergaard. P. Østergaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Myrup, Bjarne, Hiroki Yokoyama, Ole Peter Kristiansen, P. Østergaard, & Thomas Olivecrona. (2004). Release of endothelium‐associated proteins into blood by injection of heparin in normal subjects and in patients with Type 1 diabetes. Diabetic Medicine. 21(10). 1135–1140. 17 indexed citations
2.
Schmidt, Andrea, Christian Jelsch, P. Østergaard, W. Rypniewski, & Victor S. Lamzin. (2003). Trypsin Revisited. Journal of Biological Chemistry. 278(44). 43357–43362. 60 indexed citations
3.
Ducros, V.M.-A., A.M. Brzozowski, Keith S. Wilson, et al.. (2001). Structure of the laccase fromCoprinus cinereusat 1.68 Å resolution: evidence for different `type 2 Cu-depleted' isoforms. Acta Crystallographica Section D Biological Crystallography. 57(2). 333–336. 62 indexed citations
4.
Brzozowski, A.M., Keith S. Wilson, Stephen H.M. Brown, et al.. (1998). Crystal structure of the type-2 Cu depleted laccase from Coprinus dnereus at 2.2 Å resolution. Nature Structural Biology. 5(4). 310–316. 274 indexed citations
5.
Norrby, Klas & P. Østergaard. (1997). A 5.0-kD Heparin Fraction Systemically Suppresses VEGF<sub>165</sub>-Mediated Angiogenesis. PubMed. 17(6). 314–321. 21 indexed citations
6.
Ducros, V.M.-A., G.J. Davies, David M. Lawson, et al.. (1997). Crystallization and preliminary X-ray analysis of the laccase fromCoprinus cinereus. Acta Crystallographica Section D Biological Crystallography. 53(5). 605–607. 15 indexed citations
7.
8.
Larnkjær, Anni, Anders Nykjær, Gunilla Olivecrona, Henning Thøgersen, & P. Østergaard. (1995). Structure of heparin fragments with high affinity for lipoprotein lipase and inhibition of lipoprotein lipase binding to α2-macroglobulin-receptor/low-density-lipoprotein-receptor-related protein by heparin fragments. Biochemical Journal. 307(1). 205–214. 21 indexed citations
9.
Holst, Jan, Bengt Lindblad, David Bergqvist, et al.. (1994). Antithrombotic effect of recombinant truncated tissue factor pathway inhibitor (TFPI1-161) in experimental venous thrombosis--a comparison with low molecular weight heparin.. PubMed. 71(2). 214–9. 36 indexed citations
10.
Holst, Jan, Bengt Lindblad, David Bergqvist, et al.. (1994). Protamine neutralization of intravenous and subcutaneous low-molecular-weight heparin (tinzaparin, Logiparin™). An experimental investigation in healthy volunteers. Blood Coagulation & Fibrinolysis. 5(5). 795–803. 60 indexed citations
11.
Østergaard, P., et al.. (1993). Is Tissue Factor Pathway Inhibitor Involved in the Antithrombotic Effect of Heparins?. Pathophysiology of Haemostasis and Thrombosis. 23(Suppl. 1). 107–111. 25 indexed citations
12.
Hultin, Magnus, et al.. (1993). Depletion of lipoprotein lipase after heparin administration.. Arteriosclerosis and Thrombosis A Journal of Vascular Biology. 13(10). 1391–1396. 27 indexed citations
13.
14.
15.
Østergaard, P., et al.. (1991). Pharmacokinetics of a low molecular weight heparin, Logiparin, after intravenous and subcutaneous administration to healthy volunteers. Thrombosis Research. 61(5-6). 477–487. 27 indexed citations
16.
Liu, Guoquan, Gunilla Bengtsson-Olivecrona, P. Østergaard, & Thomas Olivecrona. (1991). Low-Mr heparin is as potent as conventional heparin in releasing lipoprotein lipase, but is less effective in preventing hepatic clearance of the enzyme. Biochemical Journal. 273(3). 747–752. 22 indexed citations
17.
Siegbahn, Agneta, Shams Y‐Hassan, Jonas Boberg, et al.. (1989). Subcutaneous treatment of deep venous thrombosis with low molecular weight heparin. A dose finding study with LMWH-Novo. Thrombosis Research. 55(6). 767–778. 39 indexed citations
18.
Østergaard, P., et al.. (1988). Chemistry of heparin and low molecular weight heparin.. PubMed. 543. 52–6. 13 indexed citations
19.
Østergaard, P., et al.. (1987). tPA inhibitor, tPA:Ag, plasminogen, and α2-antiplasmin after low molecular weight heparin or standard heparin. Fibrinolysis and Proteolysis. 1(1). 39–43. 18 indexed citations
20.
Gracey, Michael, P. Østergaard, & J. J. Beaman. (1979). Oropharyngeal microflora in Aboriginal and non-Aboriginal Australian children. An indicator of environmental contamination.. PubMed. 2(4). 212–4. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franz Koller Breakdown of academic impact, for papers by L.-O. Andersson Breakdown of academic impact, for papers by Anders H. Pedersen Breakdown of academic impact, for papers by Simeon Pollack Breakdown of academic impact, for papers by Utpal Chaudhuri Breakdown of academic impact, for papers by Jimmy D. Page Breakdown of academic impact, for papers by V. M. Berlin Grace Breakdown of academic impact, for papers by Werner Stüber Breakdown of academic impact, for papers by Isabel Gómez-Orellana Breakdown of academic impact, for papers by H. K. Kim
Rankless by CCL
2026